CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0316
-0.0005 (-1.65%)
Apr 3, 2025, 2:27 PM EST
CV Sciences Revenue
In the year 2024, CV Sciences had annual revenue of $15.71M, down -1.87%. CV Sciences had revenue of $3.88M in the quarter ending December 31, 2024, with 2.18% growth.
Revenue
15.71M
Revenue Growth
-1.87%
P/S Ratio
0.35
Revenue / Employee
327.19K
Employees
43
Market Cap
5.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.71M | -299.00K | -1.87% |
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 16.04M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
American Oncology Network | 1.76B |
Longduoduo Company | 6.01M |
CV Sciences News
- 7 days ago - CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results - Accesswire
- 8 days ago - CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods - Accesswire
- 13 days ago - Cannabis Stock Gainers And Losers From March 21, 2025 - Benzinga
- 14 days ago - CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025 - Accesswire
- 20 days ago - Marijuana Stock Movers For March 14, 2025 - Benzinga
- 2 months ago - CV Sciences Unveils New Aura Collection THC Fizz Tablets - Accesswire
- 4 months ago - CV Sciences enters into agreement to acquire Extract Labs - Seeking Alpha